Back to Search
Start Over
Clinical Utility of Circulating Pentraxin 3 as a Prognostic Biomarker in Coronavirus Disease 2019: A Systematic Review and Meta-analysis
- Source :
- Infectious Diseases and Therapy; January 2023, Vol. 12 Issue: 1 p67-80, 14p
- Publication Year :
- 2023
-
Abstract
- This study focuses on the relationship between circulating pentraxin 3 (PTX3) and coronavirus disease 2019 (COVID-19). COVID-19 can initiate the inflammatory reaction of the body, trigger a series of immune mechanisms, and cause death in severe cases. PTX3 is a soluble pattern recognition molecule (PRM) belonging to the humoral innate immune system, which may be increasingly deemed as an independent strong prognostic indicator in severe infectious diseases, such as COVID-19. Five databases (Pubmed, Cochrane Library, EMBASE, Clinicaltrials.gov, and gray literature) were searched for six keywords. There was no significant difference in circulating PTX3 levels between intensive care unit (ICU) and non-ICU patients with COVID-19, while the PTX3 levels of nonsurvival patients with COVID-19 was significantly lower than those of survival patients. Circulating PTX3 may indicate good diagnostic value in predicting the mortality of COVID-19, which may be useful as an indicator for monitoring.
Details
- Language :
- English
- ISSN :
- 21938229 and 21936382
- Volume :
- 12
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Infectious Diseases and Therapy
- Publication Type :
- Periodical
- Accession number :
- ejs61241911
- Full Text :
- https://doi.org/10.1007/s40121-022-00730-9